Molnupiravir is an experimental antiviral therapy Merck is developing with Ridgeback Biotherapeutics for the treatment of COVID-19 patients who are not hospitalized. The drug is currently being assessed in a late-stage trial for its …
See Original Article

Adjusted losses of 5 cents per share were narrower than the FactSet consensus for a 20-cent-per-share loss. Revenue of $109.1 million was up from $69.3 million last year and ahead of the FactSet consensus for $97.9 million.
See Original Article

“Global Lease Accounting Software Market Report Based on COVID-19 Impact Analysis by Key Players, Types, Applications, Countries, Market Size and
See Original Article

Scott Peters, senior executive VP and head of the Consumer Banking Group for Regions Bank said, “We have thoughtfully evaluated the home improvement point-of-sale lending space for a number of years, and we believe this is the right partner at the right …
See Original Article

KUALA LUMPUR (Reuters) – Top Glove Corp Bhd, the subject of a U.S. import ban over concerns about forced labour, is waiting for customs authorities there to verify remedial action it has taken on workers’ recruitment fees, the Malaysian firm said on …
See Original Article